Mordor Intelligence Private Limited: Peptide Therapeutics Market Growing at 7.16% CAGR to Reach USD 70.20 Bn by 2031 Driven by Rising Cancer Prevalence & Metabolic Disorder Burden, Reports Mordor Intelligence

Wednesday, March 25, 2026

AI Briefing

Peptide therapeutics market to grow at 7.16% CAGR to reach USD 70.20 Bn by 2031, driven by rising cancer prevalence and metabolic disorder burden.
Increasing demand for targeted and personalized treatments is driving the growth of the peptide therapeutics market.
Pharmaceutical companies are investing heavily in peptide research and development to create more effective and safe treatment options.